Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
S. Couraud(Hospices Civils de Lyon), Pierre-Jean Souquet(Lyon 1 Université), Felipe Vaca‐Paniagua(Universidad Autónoma de Tlaxcala), Tibor Schuster(Technical University of Munich), Jean Trédaniel(Hôpital Paris Saint-Joseph), Magali Olivier(Centre international de recherche sur le cancer), Bernard Duvert(Montimage (France)), Sébastien Larivé(Middle Georgia State College), Laurent Guilleminault, Maxime Vallée(Hospices Civils de Lyon), Nathalie Prim(Hôpital Civil, Strasbourg), Gérard Zalcman(Inserm), Franck Morin(Intergroupe Francophone de Cancérologie Thoracique), Stéphanie Villar(Centre international de recherche sur le cancer), J. Margery, Pascal Foucher(CHU Dijon Bourgogne), James McKay(Centre international de recherche sur le cancer), Nicolas Girard(Institut Curie), Florence Le Calvez‐Kelm(Centre international de recherche sur le cancer), Radj Gervais(Centre François Baclesse), Pascale Missy(Intergroupe Francophone de Cancérologie Thoracique), Michel Vincent(Centre Hospitalier Saint-Joseph Saint-Luc), Javier Oliver(Centre international de recherche sur le cancer), Hélène Blanché(Fondation Jean Dausset-CEPH)
Cited by 213
Related Papers
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
|The Lancet Oncology|2012|5.5k
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
|Cold Spring Harbor Perspectives in Biology|2009|2.2k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k